Nasivin Sensitive Pro Kojence (Oxymetazoline Hydrochloride)

Oxymetazoline, an alpha‑adrenergic agonist, temporarily relieves nasal congestion by reducing swelling of the nasal mucosa in several common conditions.

• Common cold: reduces nasal swelling and improves airflow during viral upper respiratory infections.
• Sinusitis: alleviates blockage and facilitates sinus drainage, helping to ease pressure.
• Allergic rhinitis: diminishes nasal blockage caused by allergen‑induced inflammation.

• Oxymetazoline acts as a selective agonist at α1‑ and α2‑adrenergic receptors on the smooth muscle of nasal mucosal blood vessels. Activation of these receptors triggers vasoconstriction, which decreases blood flow to the nasal epithelium, reducing edema and the volume of secretions. The effect appears within minutes and lasts for several hours, providing symptomatic relief without systemic action at recommended doses.

Oxymetazoline nasal spray may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects

• Nasal irritation: mild burning or stinging sensation at the application site.
• Dryness: dryness of the nasal mucosa leading to crusting.
• Sneezing: transient increase in sneezing after use.
• Headache: mild headache reported by some users.

Serious or Rare Side Effects

• Rebound congestion (rhinitis medicamentosa): prolonged use may cause worsening nasal blockage.
• Elevated blood pressure: systemic absorption can raise blood pressure in susceptible individuals.
• Cardiac arrhythmia: rare cases of tachyarrhythmia have been reported.

Before using Oxymetazoline nasal spray, consider the following precautions to ensure safe and effective use.

• Age limitation: avoid use in children under 6 years unless directed by a clinician.
• Duration of use: limit treatment to no more than three consecutive days to prevent rebound congestion.
• Cardiovascular disease: use with caution in patients with hypertension, coronary artery disease, or other heart conditions.
• Pregnancy and lactation: consult a healthcare professional before use during pregnancy or while breastfeeding.
• Drug interactions: disclose all concurrent nasal or systemic decongestants and sympathomimetic agents to a clinician.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Oxymetazoline can interact with other medications; awareness of major and moderate interactions helps avoid adverse outcomes.

Major Interactions (Avoid)

• Other nasal decongestants: concurrent use may cause excessive vasoconstriction and increase risk of hypertension.
• MAO inhibitors: combined use can precipitate hypertensive crisis due to additive sympathomimetic effects.
• Sympathomimetic drugs: simultaneous use may amplify cardiovascular stimulation.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: Oxymetazoline may reduce the effectiveness of blood pressure‑lowering medications.
• Beta‑blockers: monitor blood pressure as combined effects can lead to increased pressure.
• Tricyclic antidepressants: may increase the risk of tachycardia when used together.